Skip to main content
Premium Trial:

Request an Annual Quote

Varian Acquires FTMS Firm IonSpec for $16M in Cash

NEW YORK, Feb. 27 (GenomeWeb News) - Varian said today that it has acquired IonSpec, picking up the company's Fourier transform mass spectrometry technology.

 

Varian said that it paid $16 million in cash, including the paydown of assumed debt, for IonSpec. Additional payments could be made if products based on the FTMS technology reach specific financial targets over a three-year period.

Additional terms of the transaction were not disclosed.

 

Varian noted that the deal is part of its strategy to strengthen its detection product portfolio, which includes nuclear magnetic resonance and magnetic resonance imaging, mass spectrometry, and Fourier transform-infrared systems.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.